Source: Xconomy

Organovo: Organovo Halts Liver Tissue R&D, Plans Restructuring to Cut Costs

Organovo says it has run out of money to advance its efforts to develop 3-D "patches" of living human liver tissue to tide over people waiting for an organ transplant. The San Diego-based biotech has been working since 2007 to use a method known as bio-printing to come up with such a product, which Organovo [...]

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from Organovo's latest SEC filings

Annual Revenue

Based on data from Organovo's latest SEC filings


Taylor J. Crouch's photo - President & CEO of Organovo

President & CEO

Taylor J. Crouch

CEO Approval Rating


Organovo develops tissue and disease models for medical research and therapeutic applications.

Organovo is headquartered ...
Read more